Product Details
| Product Name:
Ikarugamycin |
CAS No.:
36531-78-9 |
| Supply Ability:
10g |
Release date:
2026/05/07 |
Product Introduction
Bioactivity
| Name | Ikarugamycin |
| Description | Ikarugamycin is a macrolide antibiotic discovered in Streptomyces, exhibiting antiprotozoal activity, inducing apoptosis and activating caspases, and also acting as a CME (clathrin-mediated endocytosis) inhibitor. |
| In vitro | In H1299 cells, the IC50 value of Ikarugamycin was 2.7 μM, and it significantly inhibited TfnR endocytosis at a concentration of 4 μM [1]. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Shipping with blue ice/Shipping at ambient temperature. |
| Keywords | Ikarugamycin | Clathrin-mediated endocytosis |
| Inhibitors Related | Neomycin sulfate | Stavudine | Aceglutamide | Urea | Tamoxifen | Kanamycin sulfate | Sulfamethoxazole sodium | Terbinafine hydrochloride | Metronidazole | Doxycycline | Formamide | Alginic acid |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
Recommended supplier
| Product name |
Price |
|
Suppliers |
Update time |
|
|
|
|
Anhui Ruihan Technology Co., Ltd
|
2023-08-21 |
United States